Renaissance Capital logo

FBRX News

US IPO Weekly Recap: Six IPOs price, Yext pops 22% and Netshoes disappears

YEXT

Six IPOs raised $1.2 billion this week, tied for the most active week of the year. Yext (YEXT) was the latest in a series of high-growth, high-loss software companies to have well-received IPOs this year. Yext allows businesses to sync...read more

Biotechs stage comeback after slow quarter

Forte Biosciences (Tocagen) logo

The US IPO market snapped back in the 1Q17, but quarterly biotech activity fell to its lowest level since the 4Q12. Just three of the 25 deals came from biotechs in the 1Q17, compared to seven of the eight in the 1Q16. Recent IPO Tocagen (TOCA)...read more

Brain power: Biotech Tocagen prices upsized IPO at $10, the low end of the range

Forte Biosciences (Tocagen) logo

Tocagen, which is developing a combination gene therapy treatment for brain cancer, raised $85 million by offering 8.5 million shares at $10. It had planned to offer 7.25 million shares at a range of $10 to $12. Tocagen plans to list on the Nasdaq under the...read more

US IPO Week Ahead: 5 deals in short week

YEXT

There are six deals on the calendar for the week ahead, after Azul was cleared by regulators to resume its IPO. After not having any deals in the first two month of the year, two tech IPOs this week should make the sector the most active year to date. We...read more